NASDAQ Companies

BROOMFIELD, Colo., Jan. 29, 2024 (GLOBE NEWSWIRE) — DMC Global Inc. (Nasdaq: BOOM) today announced its board of directors (“the […]

SINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) — CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused […]

DURHAM, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), […]

First BAW Design Win at a Tier-1 Automotive Customer in the Fast-Growing EV Market Segment Based on IC Reference Design […]

BAUDETTE, Minn., Jan. 29, 2024 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that […]

KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary […]

ZUG, Switzerland and BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company […]

BRISBANE, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (“Vera”), a late clinical-stage biotechnology company developing and commercializing […]

MINNEAPOLIS, Jan. 29, 2024 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for […]

BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) — Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells […]